Zheng Song

机构：Peking University, Tianjin Medical University Cancer Institute and Hospital, Peking University First Hospital · ORCID：0009-0007-5400-7178

发表论文 20 篇 · 总被引 94 次 · h-index 6

代表论文

• Human γδ T cell identification from single-cell RNA sequencing datasets by modular TCR expression (2023 · Journal of Leukocyte Biology · 被引 25)
• <p>Chloroquine Combined with Imatinib Overcomes Imatinib Resistance in Gastrointestinal Stromal Tumors by Inhibiting Autophagy via the MAPK/ERK Pathway</p> (2020 · OncoTargets and Therapy · 被引 16)
• HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis (2024 · Current Cancer Drug Targets · 被引 14)
• The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis (2023 · Hepatology · 被引 12)
• Prognostic value of lymphocyte to monocyte ratio in patients with esophageal cancer: a systematic review and meta-analysis (2024 · Frontiers in Oncology · 被引 9)
• Serum Exosome–Derived microRNA-193a-5p and miR-381-3p Regulate Adenosine 5'-Monophosphate–Activated Protein Kinase/Transforming Growth Factor Beta/Smad2/3 Signaling Pathway and Promote Fibrogenesis (2023 · Clinical and Translational Gastroenterology · 被引 6)